Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Go back to Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
(NASDAQ: CRVS) Delayed: 12.63 +0.07 (0.56%)
Previous Close $12.56    52 Week High $17.77 
Open $12.10    52 Week Low $9.63 
Day High $13.07    P/E N/A 
Day Low $12.09    EPS $0.00 
Volume 920,030